Find out how black seed helps with the following:

Testimonials

I have had bronchitis for as long as I can remember.
I have had bronchitis for as long as I can remember. Every year, it got worst until finally the Doctors told me I had adult onset asthma. I tried the gel tabs about 4 days ago. I could hardly believe that within hours of the first dose, I was able to take nice deep breaths. I'm looking forward to swimming and jogging again when the weather warms up.

Marcy H.
Tallahassee, FL

Product Categories

Treating Diabetes with Black Seed
Diabetes Fact Sheet PDF Print E-mail

Video Source Credit: Diabetes UK - diabetes.org.uk

 

Data from the 2011 National Diabetes Fact Sheet (released Jan. 26, 2011)

 

Total prevalence of diabetes

 

Total: 25.8 million children and adults in the United States—8.3% of the population—have diabetes.

Diagnosed: 18.8 million people

Undiagnosed: 7.0 million people

Prediabetes: 79 million people*

New Cases: 1.9 million new cases of diabetes are diagnosed in people aged 20 years and older in 2010.

* In contrast to the 2007 National Diabetes Fact Sheet, which used fasting glucose data to estimate undiagnosed diabetes and prediabetes, the 2011 National Diabetes Fact Sheet uses both fasting glucose and A1C levels to derive estimates for undiagnosed diabetes and prediabetes. These tests were chosen because they are most frequently used in clinical practice.

Under 20 years of age

  • 215,000, or 0.26% of all people in this age group have diabetes
  • About 1 in every 400 children and adolescents has diabetes

Age 20 years or older

  • 25.6 million, or 11.3% of all people in this age group have diabetes

Age 65 years or older

  • 10.9 million, or 26.9% of all people in this age group have diabetes

Men

  • 13.0 million, or 11.8% of all men aged 20 years or older have diabetes

Women

  • 12.6 million, or 10.8% of all women aged 20 years or older have diabetes

Race and ethnic differences in prevalence of diagnosed diabetes

After adjusting for population age differences, 2007-2009 national survey data for people diagnosed with diabetes, aged 20 years or older include the following prevalence by race/ethnicity:

  • 7.1% of non-Hispanic whites
  • 8.4% of Asian Americans
  • 12.6% of non-Hispanic blacks
  • 11.8% of Hispanics

Among Hispanics rates were:

  • 7.6% for Cubans
  • 13.3% for Mexican Americans
  • 13.8% for Puerto Ricans.

Morbidity and Mortality

  • In 2007, diabetes was listed as the underlying cause on 71,382 death certificates and was listed as a contributing factor on an additional 160,022 death certificates. This means that diabetes contributed to a total of 231,404 deaths.

Complications

Heart disease and stroke

  • In 2004, heart disease was noted on 68% of diabetes-related death certificates among people aged 65 years or older.
  • In 2004, stroke was noted on 16% of diabetes-related death certificates among people aged 65 years or older.
  • Adults with diabetes have heart disease death rates about 2 to 4 times higher than adults without diabetes.
  • The risk for stroke is 2 to 4 times higher among people with diabetes.

High blood pressure

  • In 2005-2008, of adults aged 20 years or older with self-reported diabetes, 67% had blood pressure greater than or equal to 140/90 mmHg or used prescription medications for hypertension.

Blindness

  • Diabetes is the leading cause of new cases of blindness among adults aged 20–74 years.
  • In 2005-2008, 4.2 million (28.5%) people with diabetes aged 40 years or older had diabetic retinopathy, and of these, almost 0.7 million (4.4% of those with diabetes) had advanced diabetic retinopathy that could lead to severe vision loss.

Kidney disease

  • Diabetes is the leading cause of kidney failure, accounting for 44% of new cases in 2008.
  • In 2008, 48,374 people with diabetes began treatment for end-stage kidney disease in the United States.
  • In 2008, a total of 202,290 people with end-stage kidney disease due to diabetes were living on chronic dialysis or with a kidney transplant in the United States.

Nervous system disease (Neuropathy)

  • About 60% to 70% of people with diabetes have mild to severe forms of nervous system damage.

Amputation

  • More than 60% of nontraumatic lower-limb amputations occur in people with diabetes.
  • In 2006, about 65,700 nontraumatic lower-limb amputations were performed in people with diabetes.

Cost of Diabetes

  • $174 billion: Total costs of diagnosed diabetes in the United States in 2007
  • $116 billion for direct medical costs
  • $58 billion for indirect costs (disability, work loss, premature mortality)

After adjusting for population age and sex differences, average medical expenditures among people with diagnosed diabetes were 2.3 times higher than what expenditures would be in the absence of diabetes.

The American Diabetes Association has created a Diabetes Cost Calculator that takes the national cost of diabetes data and provides estimates at the state and congressional district level.

Factoring in the additional costs of undiagnosed diabetes, prediabetes, and gestational diabetes brings the total cost of diabetes in the United States in 2007 to $218 billion.

  • $18 billion for people with undiagnosed diabetes
  • $25 billion for American adults with prediabetes
  • $623 million for gestational diabetes

For Additional Information

These stastics and additional information can be found in the National Diabetes Fact Sheet, 2011, the most recent comprehensive assessment of the impact of diabetes in the United States, jointly produced by the CDC, NIH, ADA, and other organizations.
Last Updated on Wednesday, 28 March 2012 07:15
 
Treating Diabetes with Black Seed PDF Print E-mail

Diabetes mellitus results in severe metabolic imbalances and pathological changes in many tissues. Oxidative stress has been shown to play an important role in the etiology of diabetes and diabetic complications. Diabetics exhibit high-oxidative stress due to persistent and chronic hyperglycemia, thereby reducing the activity of the antioxidative defense system and thus promoting free radical generation.

Several interactive pathogenetic mechanisms of diabetic peripheral neuropathy have been identified in both human and murine models and persistent hyperglycaemia has been regarded as a primary risk factor for neuropathy. Long-term hyperglycaemia can lead to subsequent enhanced oxidative stress, increased aldose reductase activity, and accumulation of advanced glycation endproducts (AGE). As a result, it could induce progressive damage to the peripheral sensory and autonomic nervous systems. To date, except for rigorous glycaemic control, there are few means to affect or slow the natural progression of diabetic peripheral neuropathy owing to limitations of the current and often inadequate drug therapy.

However, in a recent animal study, scientists found Nigella Sativa (also known as Black Seed or Black Cumin) and its pharmacologically active substance thymoquinone, affected blood glucose levels, and insulin. Furthermore, they suggested that the antioxidant activity of Black Seed may alleviate damage to b-cells in the pancreas. The study found less damage to tissues in diabetic animals treated with black seed and thymoquinone. The researchers concluded that the neuroprotective effects of thymoquinone and especially black seed are attributed to its direct and indirect antioxidant actions.

 

Babaei-Jadidi R, Karachalias N, Ahmed N, et al. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes. 2003 Aug;52(8):2110-20.

Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991 Apr;40(4):405-12.

Cameron NE, Cotter MA, Basso M, et al. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia. 1997 Mar;40(3):271-81.

Kanter M. Effects of Nigella Sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res. 2008 Jan;33(1):87-96.

Karachalias N, Babaei-Jadidi R, Ahmed N, et al. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans. 2003 Dec;31(Pt 6):1423-5.

Le PM, Benhaddou-Andaloussi A, Elimadi A, et al. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J Ethnopharmacol. 2004 Oct;94(2-3):251-9.

[No authors listed] The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med. 1995 Apr 15;122(8):561-8.

[No authors listed] Failure of improved glycaemic control to reverse diabetic autonomic neuropathy. The St Thomas's Diabetic Study Group. Diabet Med. 1986 Jul-Aug;3(4):330-4.

Thorpe SR, Baynes JW. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging. 1996 Aug;9(2):69-77.

Vague P, Coste TC, Jannot MF, et al. C-peptide, Na+,K(+)-ATPase, and diabetes. Exp Diabesity Res. 2004 Jan-Mar;5(1):37-50.

 

TESTIMONIALS

I started taking the capsules this year during the cold and flu season to help my immune system.

I started taking the capsules this year during the cold and flu season to help my immune system. For several weeks my co-workers were getting sick one after another, but I felt healthier than usual. I was amazed at how much stronger I felt! Eventually I did catch the cough/cold that had been going around (stress and extended lack of sleep will do that to you, no matter how strong your immunity). However, I got better at least 5 times faster than my co-workers with the same illness -- I only had to take 1 sick day. With a high-stress job, this is a supplement I don't want to go without. The other benefits (clearing skin, improving hair) are a nice bonus, too!

Amina
Alexandria, Virginia

WRITE YOUR OWN REVIEW!

Now in your cart 0 items

 
Last Updated on Saturday, 28 April 2012 11:21